Aenitis Technologies Receives €4M in Funding from EU
Summary
Aenitis Technologies, a Paris, France-based developer of new medical equipment based on acoustic manipulation of biological particles, received €4m in funding.The funding came from the SME Instrument Phase 2 European program, part of Horizon 2020, in the “Healthcare Biotechnology” category.The financing will enable the company accelerate the industrial development of its solutions.Led by Emmanuel Vincent, CEO and co-founder, Aenitis Technologies Created in July 2014 from the work of Mauricio Hoyos and Jean-Luc Aider, Aenitis Technologies focuses on medical devices’ area, developing innovative separation, manipulation and filtration of biological elements solutions, based on acoustophoresis technologies.FinSMEs 01/12/2017
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected